✨Dr. Brad Corr, A CU Gynecologic Oncologist, is dispelling clinical trial myths! 🧪✅ Safe, innovative treatments empower patients to make informed care decisions.
📖 Read more: bit.ly/4hAKCGW
#OvarianCancer #GynOnc #CUAnschutz
📖 Read more: bit.ly/4hAKCGW
#OvarianCancer #GynOnc #CUAnschutz
Debunking 8 Myths About Cancer Clinical Trials
Misunderstandings about cancer clinical trials – what they are and how they work – keep some people from accessing the life-saving treatments they offer.
bit.ly
October 27, 2025 at 6:14 PM
✨Dr. Brad Corr, A CU Gynecologic Oncologist, is dispelling clinical trial myths! 🧪✅ Safe, innovative treatments empower patients to make informed care decisions.
📖 Read more: bit.ly/4hAKCGW
#OvarianCancer #GynOnc #CUAnschutz
📖 Read more: bit.ly/4hAKCGW
#OvarianCancer #GynOnc #CUAnschutz
Oncology experts will be joining our friends and collaborators at COR2ED in Berlin for #ESMO25
Coming Soon👉 cor2ed.com/esmo-2025/up...
They will share their insights on the latest data on #BladderCancer #KidneyCancer #ProstateCancer #LungCancer #BreastCancer #GynOnc and Upper GI Cancers
Sign up
Coming Soon👉 cor2ed.com/esmo-2025/up...
They will share their insights on the latest data on #BladderCancer #KidneyCancer #ProstateCancer #LungCancer #BreastCancer #GynOnc and Upper GI Cancers
Sign up
October 18, 2025 at 12:30 PM
Oncology experts will be joining our friends and collaborators at COR2ED in Berlin for #ESMO25
Coming Soon👉 cor2ed.com/esmo-2025/up...
They will share their insights on the latest data on #BladderCancer #KidneyCancer #ProstateCancer #LungCancer #BreastCancer #GynOnc and Upper GI Cancers
Sign up
Coming Soon👉 cor2ed.com/esmo-2025/up...
They will share their insights on the latest data on #BladderCancer #KidneyCancer #ProstateCancer #LungCancer #BreastCancer #GynOnc and Upper GI Cancers
Sign up
Toni Moses, RN, is battling stage IV ovarian cancer while helping others—and participating in a trial led by Dr. Brad Corr & the CU Ovarian Cancer Innovations Group. 💙 Read her powerful story: news.cuanschutz.edu/cancer-cente...
#OvarianCancer #GynOnc #CUAnschutz
#OvarianCancer #GynOnc #CUAnschutz
‘I Love What I Do’: While She Helps Patients, a Nurse Grapples with Her Own Ovarian Cancer
Toni Moses, RN, says she’s grateful to be enrolled in a clinical trial led by Bradley Corr, MD, of the CU Cancer Center.
news.cuanschutz.edu
October 1, 2025 at 7:16 PM
Toni Moses, RN, is battling stage IV ovarian cancer while helping others—and participating in a trial led by Dr. Brad Corr & the CU Ovarian Cancer Innovations Group. 💙 Read her powerful story: news.cuanschutz.edu/cancer-cente...
#OvarianCancer #GynOnc #CUAnschutz
#OvarianCancer #GynOnc #CUAnschutz
The #OncoAlertColloquium 🚨 #GYNONC
REGISTER for FREE HERE👉 https://buff.ly/3WPcQ7m @AStrojnaMD 🇩🇪 Reviewing Endometrial Cancer: Surgical Oncology JOIN US for a Live chat with Dr. Strojna
In 2024, several unaddressed needs and unresolved questions in endometrial cancer treatment were highlighted
REGISTER for FREE HERE👉 https://buff.ly/3WPcQ7m @AStrojnaMD 🇩🇪 Reviewing Endometrial Cancer: Surgical Oncology JOIN US for a Live chat with Dr. Strojna
In 2024, several unaddressed needs and unresolved questions in endometrial cancer treatment were highlighted
February 7, 2025 at 5:50 PM
The #OncoAlertColloquium 🚨 #GYNONC
REGISTER for FREE HERE👉 https://buff.ly/3WPcQ7m @AStrojnaMD 🇩🇪 Reviewing Endometrial Cancer: Surgical Oncology JOIN US for a Live chat with Dr. Strojna
In 2024, several unaddressed needs and unresolved questions in endometrial cancer treatment were highlighted
REGISTER for FREE HERE👉 https://buff.ly/3WPcQ7m @AStrojnaMD 🇩🇪 Reviewing Endometrial Cancer: Surgical Oncology JOIN US for a Live chat with Dr. Strojna
In 2024, several unaddressed needs and unresolved questions in endometrial cancer treatment were highlighted
🎉 Season 1 Finale of MED ED MATTERS!
🎙️ @docohms.bsky.social chats with Drs. Meredith Newton & Jenny Haag to talk Educational Time Outs & teaching in the OR.
🎧Tune in! #MedEd #GynOnc
Youtube: youtu.be/1DEDft9lot0
Spotify: open.spotify.com/episode/757y...
Apple: podcasts.apple.com/us/podcast/e...
🎙️ @docohms.bsky.social chats with Drs. Meredith Newton & Jenny Haag to talk Educational Time Outs & teaching in the OR.
🎧Tune in! #MedEd #GynOnc
Youtube: youtu.be/1DEDft9lot0
Spotify: open.spotify.com/episode/757y...
Apple: podcasts.apple.com/us/podcast/e...
May 22, 2025 at 3:49 PM
🎉 Season 1 Finale of MED ED MATTERS!
🎙️ @docohms.bsky.social chats with Drs. Meredith Newton & Jenny Haag to talk Educational Time Outs & teaching in the OR.
🎧Tune in! #MedEd #GynOnc
Youtube: youtu.be/1DEDft9lot0
Spotify: open.spotify.com/episode/757y...
Apple: podcasts.apple.com/us/podcast/e...
🎙️ @docohms.bsky.social chats with Drs. Meredith Newton & Jenny Haag to talk Educational Time Outs & teaching in the OR.
🎧Tune in! #MedEd #GynOnc
Youtube: youtu.be/1DEDft9lot0
Spotify: open.spotify.com/episode/757y...
Apple: podcasts.apple.com/us/podcast/e...
Momie Yamamoto and Ritz Iwanaga from Dr. Bitler's lab at CU Anschutz recently submitted a paper showing that Chromobox2 (CBX2) plays a role in driving HGSC progression. This suggests a potential new treatment option for HGSC patients. Wish them luck publishing their paper #HGSC #GynOnc #CUAnschutz
March 26, 2025 at 2:58 PM
Momie Yamamoto and Ritz Iwanaga from Dr. Bitler's lab at CU Anschutz recently submitted a paper showing that Chromobox2 (CBX2) plays a role in driving HGSC progression. This suggests a potential new treatment option for HGSC patients. Wish them luck publishing their paper #HGSC #GynOnc #CUAnschutz
Synapse: Your Connection to our MSK Authors
Meet: Matthew Laurence Flint
Research Focus: Graduate Staff; Fellow
#OvarianCancerResearch #FOLR1TargetedTherapy
#Mirvetuximab #ADCTherapy #OncologyOutcomes #TargetedCancerTherapy #GynOnc #CancerResearch
synapse.mskcc.org/synapse/work...
Meet: Matthew Laurence Flint
Research Focus: Graduate Staff; Fellow
#OvarianCancerResearch #FOLR1TargetedTherapy
#Mirvetuximab #ADCTherapy #OncologyOutcomes #TargetedCancerTherapy #GynOnc #CancerResearch
synapse.mskcc.org/synapse/work...
August 14, 2025 at 12:18 PM
Synapse: Your Connection to our MSK Authors
Meet: Matthew Laurence Flint
Research Focus: Graduate Staff; Fellow
#OvarianCancerResearch #FOLR1TargetedTherapy
#Mirvetuximab #ADCTherapy #OncologyOutcomes #TargetedCancerTherapy #GynOnc #CancerResearch
synapse.mskcc.org/synapse/work...
Meet: Matthew Laurence Flint
Research Focus: Graduate Staff; Fellow
#OvarianCancerResearch #FOLR1TargetedTherapy
#Mirvetuximab #ADCTherapy #OncologyOutcomes #TargetedCancerTherapy #GynOnc #CancerResearch
synapse.mskcc.org/synapse/work...
Join ESMOGynae25 to Be Part of an International Exchange of Knowledge and Innovation in Gynaecological Oncology – ESMO
@myesmo.bsky.social
oncodaily.com/blog/esmogyn...
#OncoDaily #Oncology #Cancer #Health #Medicine #MedEd #MedOnc #MedNews #ESMOGynae25 #ESMO #GynOnc
@myesmo.bsky.social
oncodaily.com/blog/esmogyn...
#OncoDaily #Oncology #Cancer #Health #Medicine #MedEd #MedOnc #MedNews #ESMOGynae25 #ESMO #GynOnc
Join for ESMOGynae25 to Be Part of an International Exchange of Knowledge and Innovation in Gynaecological Oncology - ESMO - OncoDaily
Join for ESMOGynae25 to Be Part of an International Exchange of Knowledge and Innovation in Gynaecological Oncology - ESMO / cancer, ESMO, ESMO - Eur.
oncodaily.com
June 10, 2025 at 9:09 PM
Join ESMOGynae25 to Be Part of an International Exchange of Knowledge and Innovation in Gynaecological Oncology – ESMO
@myesmo.bsky.social
oncodaily.com/blog/esmogyn...
#OncoDaily #Oncology #Cancer #Health #Medicine #MedEd #MedOnc #MedNews #ESMOGynae25 #ESMO #GynOnc
@myesmo.bsky.social
oncodaily.com/blog/esmogyn...
#OncoDaily #Oncology #Cancer #Health #Medicine #MedEd #MedOnc #MedNews #ESMOGynae25 #ESMO #GynOnc
Excited to attend Oncofertility 2025 at Hammersmith Hospital! 🎗️ organised by my PhD mentor, Mr. Srdjan Saso, my work focuses on diagnosing ovarian cancer in pregnancy and children, so I’m eager to explore the latest in fertility preservation & gynae-oncology.
#Oncofertility2025 #GynOnc
#Oncofertility2025 #GynOnc
March 4, 2025 at 9:50 AM
Excited to attend Oncofertility 2025 at Hammersmith Hospital! 🎗️ organised by my PhD mentor, Mr. Srdjan Saso, my work focuses on diagnosing ovarian cancer in pregnancy and children, so I’m eager to explore the latest in fertility preservation & gynae-oncology.
#Oncofertility2025 #GynOnc
#Oncofertility2025 #GynOnc
High-grade serous carcinoma is a tough ovarian cancer to treat and often recurs after chemotherapy. Dr. Marjon recently resubmitted a paper showing that targeting certain tumor immune cells could help make treatments like chemotherapy more effective. Wishing her luck🤞 #HGSC #CUAnschutz #GynOnc
April 15, 2025 at 5:55 PM
High-grade serous carcinoma is a tough ovarian cancer to treat and often recurs after chemotherapy. Dr. Marjon recently resubmitted a paper showing that targeting certain tumor immune cells could help make treatments like chemotherapy more effective. Wishing her luck🤞 #HGSC #CUAnschutz #GynOnc
her eggs have left the building 😂 sharing that one around gynonc 🥲😂😂😂
October 19, 2024 at 4:59 PM
her eggs have left the building 😂 sharing that one around gynonc 🥲😂😂😂
This is encouraging. Reimbursement rates for OBGYN care are way too low. For instance, my #GynOnc friends explained that their surgeries are reimbursed less than similarly complex and time-consuming surgeries by other surgical specialties.
www.prnewswire.com/news-release...
www.prnewswire.com/news-release...
Women's Health PAC Announces Significant Milestones Including Launch of First-ever Bipartisan Women's Health Reimbursement Summit, Strategic Growth Plans and Merger with Doctors For Fertility PAC
/PRNewswire/ -- Today, the Women's Health PAC (WHPAC), the first bipartisan organization dedicated to bridging the political divide to support increased...
www.prnewswire.com
February 6, 2025 at 2:30 AM
This is encouraging. Reimbursement rates for OBGYN care are way too low. For instance, my #GynOnc friends explained that their surgeries are reimbursed less than similarly complex and time-consuming surgeries by other surgical specialties.
www.prnewswire.com/news-release...
www.prnewswire.com/news-release...
Today begins #OvarianCancerAwarenessMonth. I was stage 3 when my cancer was found. I'm 3 1/2 years "no evidence of disease". Annual CT in October. GYNONC every 3 months for a CA 125 check. Still get pelvic exams and pap smears. I take an estrogen suppressor. Know your risks. OCRAhope.org
Ovarian Cancer Research Alliance | OCRA
Ovarian Cancer Research Alliance (OCRA) is the largest global nonprofit advancing ovarian cancer research while supporting patients and their families.
Ocrahope.org
September 1, 2024 at 5:31 PM
Today begins #OvarianCancerAwarenessMonth. I was stage 3 when my cancer was found. I'm 3 1/2 years "no evidence of disease". Annual CT in October. GYNONC every 3 months for a CA 125 check. Still get pelvic exams and pap smears. I take an estrogen suppressor. Know your risks. OCRAhope.org
The #OncoAlertColloquium 🚨 #GYNONC
REGISTER for FREE HERE👉 https://buff.ly/3WPcQ7m @ChargariC 🇫🇷 Reviewing Vaginal & Vulvar Cancer: Medical Oncology JOIN US for a Live chat with Dr. Cyrus Chargari
These are Rare Tumors
REGISTER for FREE HERE👉 https://buff.ly/3WPcQ7m @ChargariC 🇫🇷 Reviewing Vaginal & Vulvar Cancer: Medical Oncology JOIN US for a Live chat with Dr. Cyrus Chargari
These are Rare Tumors
February 7, 2025 at 6:15 PM
The #OncoAlertColloquium 🚨 #GYNONC
REGISTER for FREE HERE👉 https://buff.ly/3WPcQ7m @ChargariC 🇫🇷 Reviewing Vaginal & Vulvar Cancer: Medical Oncology JOIN US for a Live chat with Dr. Cyrus Chargari
These are Rare Tumors
REGISTER for FREE HERE👉 https://buff.ly/3WPcQ7m @ChargariC 🇫🇷 Reviewing Vaginal & Vulvar Cancer: Medical Oncology JOIN US for a Live chat with Dr. Cyrus Chargari
These are Rare Tumors
Congrats to Scott Lin, MD, PhD Candidate, on receiving the Cancer Biology T32 award from the National Cancer Institute! This prestigious award supports 5 predoctoral students each year with funding through the University of Colorado Cancer Center. 🎉🎉 #CUAnschutz #GynOnc @uccc-gorg.bsky.social
July 31, 2025 at 8:26 PM
Congrats to Scott Lin, MD, PhD Candidate, on receiving the Cancer Biology T32 award from the National Cancer Institute! This prestigious award supports 5 predoctoral students each year with funding through the University of Colorado Cancer Center. 🎉🎉 #CUAnschutz #GynOnc @uccc-gorg.bsky.social
Welcome to the University of Colorado's Gyn Oncology research account, including the Division of Reproductive Sciences (DRS) & Gynecologic Oncology, as well as our Gyn Oncology research collaborators! Stay updated on research in GynOnc and women's health. #GynOnc #CUDRS #CUAnschutz #WomensHealth
March 11, 2025 at 8:53 PM
Welcome to the University of Colorado's Gyn Oncology research account, including the Division of Reproductive Sciences (DRS) & Gynecologic Oncology, as well as our Gyn Oncology research collaborators! Stay updated on research in GynOnc and women's health. #GynOnc #CUDRS #CUAnschutz #WomensHealth
The #OncoAlertColloquium 🚨 #GYNONC
REGISTER for FREE HERE👉 https://buff.ly/3WPcQ7m Dr. Annamaria Ferrero 🇮🇹 Reviewing Endometrial Cancer: Medical Oncology JOIN US for a Live chat with Dr. Ferrero
In 2024, several key changes in endometrial cancer (EC) treatment emerged.
REGISTER for FREE HERE👉 https://buff.ly/3WPcQ7m Dr. Annamaria Ferrero 🇮🇹 Reviewing Endometrial Cancer: Medical Oncology JOIN US for a Live chat with Dr. Ferrero
In 2024, several key changes in endometrial cancer (EC) treatment emerged.
February 7, 2025 at 5:22 PM
The #OncoAlertColloquium 🚨 #GYNONC
REGISTER for FREE HERE👉 https://buff.ly/3WPcQ7m Dr. Annamaria Ferrero 🇮🇹 Reviewing Endometrial Cancer: Medical Oncology JOIN US for a Live chat with Dr. Ferrero
In 2024, several key changes in endometrial cancer (EC) treatment emerged.
REGISTER for FREE HERE👉 https://buff.ly/3WPcQ7m Dr. Annamaria Ferrero 🇮🇹 Reviewing Endometrial Cancer: Medical Oncology JOIN US for a Live chat with Dr. Ferrero
In 2024, several key changes in endometrial cancer (EC) treatment emerged.
I let someone run my GynOnc support group while I was out on leave and I’m anxious to hear how it went!!!!
November 15, 2024 at 4:32 PM
I let someone run my GynOnc support group while I was out on leave and I’m anxious to hear how it went!!!!
MASCC - New Study Explores Sexual Health After Chemotherapy for Breast and Gynecologic Cancer
@cancercaremascc.bsky.social
oncodaily.com/science/gyne...
#OncoDaily #Oncology #Cancer #Health #Medicine #MedEd #MedOnc #MedNews #MASCC #GynOnc #SexualHealth #BreastCancer #GynecologicCancer
@cancercaremascc.bsky.social
oncodaily.com/science/gyne...
#OncoDaily #Oncology #Cancer #Health #Medicine #MedEd #MedOnc #MedNews #MASCC #GynOnc #SexualHealth #BreastCancer #GynecologicCancer
New Study Explores Sexual Health After Chemotherapy for Breast and Gynecologic Cancer - MASCC - OncoDaily
New Study Explores Sexual Health After Chemotherapy for Breast and Gynecologic Cancer - MASCC / cancer, Katherine Conroy, Kristen M. Carpenter, Lora L. Black,
oncodaily.com
August 30, 2025 at 12:54 AM
MASCC - New Study Explores Sexual Health After Chemotherapy for Breast and Gynecologic Cancer
@cancercaremascc.bsky.social
oncodaily.com/science/gyne...
#OncoDaily #Oncology #Cancer #Health #Medicine #MedEd #MedOnc #MedNews #MASCC #GynOnc #SexualHealth #BreastCancer #GynecologicCancer
@cancercaremascc.bsky.social
oncodaily.com/science/gyne...
#OncoDaily #Oncology #Cancer #Health #Medicine #MedEd #MedOnc #MedNews #MASCC #GynOnc #SexualHealth #BreastCancer #GynecologicCancer
Every one of my doctors has free parking EXCEPT my GynOnc & it pisses me off. Like I already have to see an oncologist and now I have to pay for parking?? The indignity.
July 2, 2025 at 10:30 PM
Every one of my doctors has free parking EXCEPT my GynOnc & it pisses me off. Like I already have to see an oncologist and now I have to pay for parking?? The indignity.
Congrats to Drs. Ben Bitler and Jim Lambert on receiving an award from Golfers Against Cancer to advance ovarian cancer immunogenic cell death (ICD) research — pushing boundaries in cancer research #OvarianCancer #GynOnc #CUAnschutz 👏👏 @uccc-gorg.bsky.social
August 5, 2025 at 7:35 PM
Congrats to Drs. Ben Bitler and Jim Lambert on receiving an award from Golfers Against Cancer to advance ovarian cancer immunogenic cell death (ICD) research — pushing boundaries in cancer research #OvarianCancer #GynOnc #CUAnschutz 👏👏 @uccc-gorg.bsky.social
Short-Course Adjuvant Vaginal Cuff Brachytherapy in Early Endometrial Cancer Compared with Standard of Care (SAVE): A Randomized Clinical Trial— new today from #JCOOA #oncsky #JCOOncologyAdvances #JCOJournals #gynonc
ascopubs.org/doi/10.1200/...
ascopubs.org/doi/10.1200/...
ASCO Publications
ascopubs.org
December 4, 2024 at 9:53 PM
Short-Course Adjuvant Vaginal Cuff Brachytherapy in Early Endometrial Cancer Compared with Standard of Care (SAVE): A Randomized Clinical Trial— new today from #JCOOA #oncsky #JCOOncologyAdvances #JCOJournals #gynonc
ascopubs.org/doi/10.1200/...
ascopubs.org/doi/10.1200/...
Levi Watson, PhD, will be presenting on “Hematopoietic Stem Cell–Derived Adipocytes Influence the Ovarian Cancer Microenvironment” at the Ovarian Cancer Midwest Focus (OCMF) Conference in Minneapolis, MN, on November 10–11, 2025. For more information, visit: bit.ly/3JJy1oa
#CUAnschutz #GynOnc
#CUAnschutz #GynOnc
November 5, 2025 at 9:39 PM
Levi Watson, PhD, will be presenting on “Hematopoietic Stem Cell–Derived Adipocytes Influence the Ovarian Cancer Microenvironment” at the Ovarian Cancer Midwest Focus (OCMF) Conference in Minneapolis, MN, on November 10–11, 2025. For more information, visit: bit.ly/3JJy1oa
#CUAnschutz #GynOnc
#CUAnschutz #GynOnc